Salarius Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4 |
Gross Profit | -1 | -1 | -1 | 2 |
EBITDA | -872 | -964 | -1,717 | -1,487 |
EBIT | -873 | -965 | -1,718 | -1,488 |
Net Income | -873 | -957 | -1,709 | -1,463 |
Net Change In Cash | 0 | 0 | 0 | 4 |
Free Cash Flow | -1,646 | -862 | -1,181 | -742 |
Cash | 4,809 | 794 | 1,798 | 2,434 |
Basic Shares | 481 | 142 | 111 | 64 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,840 |
Gross Profit | -4 | -10 | -6 | 1,821 |
EBITDA | -5,729 | -12,884 | -22,968 | -12,793 |
EBIT | -5,734 | -12,894 | -22,975 | -12,812 |
Net Income | -5,575 | -12,542 | -31,607 | -12,768 |
Net Change In Cash | 0 | 0 | 0 | 1,840 |
Free Cash Flow | -4,525 | -12,846 | -19,095 | -10,200 |
Cash | 2,434 | 5,899 | 12,106 | 29,214 |
Basic Shares | 64 | 218 | 142 | 13 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.81 |
2025-06-30 | -$0.45 |
2025-03-31 | -$1.01 |
2024-12-31 | -$1.01 |
